Answers are grounded in this paper and cite their sources.
Exploration of immune signatures reveals potential for immunotherapy in glioblastoma using mouse models, indicating new treatment avenues.
Our humanized GBM mouse model exhibited an immune cell signature similar to that of human recurrent GBM. This model is a valuable resource for analyzing the tumor immune landscape and assessing new therapies, particularly immunotherapies.
No takes yet. Share an insight, caveat, or question.
Takei et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: